Skip to content
Navigate to homepage - Cerba Research

Cerba Research is officially a member of Hong Kong Bio-Med Innotech Association (HKBMIA)

Ghent, Belgium, 11 January 2023 Cerba Research announces membership of HKBMIA as an advisor on specialty testing and routine clinical trials testing to advance research and health while supporting Asia pacific healthcare companies develop new therapeutics. 

HKBMIA actively introduces bio-pharmaceutical innovation technology projects from overseas and assist in various aspects, including fundraising, R&D technology, patent protection, regulations, valuation, clinical trial design and planning, contract development manufacture, project commercialization to enter Mainland China and Asia markets. 

Through collaboration with members of HKBMIA, Cerba Research aims to deepen the understanding on the role of specialty testing with a multi-specialist laboratory provider to support the research and development of new therapeutics. 

“The ambition of HKBMIA is to promote communication, exchange and cooperation amongst the biomedical innovation technology industry, research institutions, investment industry and government organizations. The understanding of Asia pacific companies regarding contract research organisations and central and specialty lab testing is limited, and the assistance that Cerba Research can provide to our bio-tech members will be decisive in helping them achieve their clinical and commercial objectives” says Professor Lo, president of HKBMIA

“We are delighted that HKBMIA has welcomed Cerba Research into their network and look forward to sharing our expertise with the Chinese market. Our collaboration with Prof Lo and HKBMIA builds on a decade of collaboration within China and reflects our continuing ambition to facilitate research and development in the region and support innovative Chinese biopharmaceutical customers to expand beyond their shores” adds Daniel Tanner, Chief Commercial Officer, Cerba Research. 

About Cerba Research 

Cerba Research is a global next-generation drug development company with integrated, end-to-end research, development and diagnostic solutions to optimize R&D productivity and commercialization. Cerba Research provides global clinical trial central & specialty laboratory and IVD solutions, across a range of therapeutic areas to advance research and health. 


HK Bio-Med Innotech Association (HKBMIA) was founded by Prof Lo Yuk Lam (former Chairman, Advisory Council On Food And Environmental Hygiene, Food And Health Bureau, Government Secretariat HKSAR) and experts from the biotechnology industry and the investment industry in 2017. HKBMIA is committed to establishing an innovative and international biomedical technology platform in Hong Kong, promoting communication, exchange and cooperation amongst the biomedical innovation technology industry, research institutions, investment industry and government organizations in the Greater China Region in the areas of innovative R&D, industrialization, regulations and policies coordination, investment and financing.

Cerba US Expansion Tour VF.00_04_27_19.Still010

Reach out to our experts and discover how we can help you advance your research

Contact Us